Description

2-(2-Cyclopropaneamido-1,3-Thiazol-4-Yl)Acetic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its unique heterocyclic structure combining cyclopropane and thiazole moieties. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in the development of targeted therapeutic agents. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and process chemistry for anti-infective and anti-inflammatory applications.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly those targeting specific enzymatic pathways.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization in academic and industrial labs.
• Active Pharmaceutical Ingredient (API) Synthesis: Serves as a precursor in multi-step synthetic routes for complex molecules with potential therapeutic value.
• Bioconjugation & Probe Development: The carboxylic acid functional group allows for conjugation to other molecules, useful in creating diagnostic probes or targeted drug delivery systems.
• Chemical Biology: Employed as a tool compound to study biological processes and protein-ligand interactions due to its specific structural features.

Basic Information

Product Name	2-(2-Cyclopropaneamido-1,3-Thiazol-4-Yl)Acetic Acid
CAS No.	926246-95-9
Molecular Formula	C9H10N2O3S
Molecular Weight	226.25 g/mol
Synonyms	2-[(2-Cyclopropanecarboxamido)-1,3-thiazol-4-yl]acetic acid; 4-Thiazoleacetic acid, 2-(cyclopropanecarboxamido)-; 2-(2-Cyclopropanecarboxamidothiazol-4-yl)acetic acid; 2-(2-Cyclopropanecarboxamido-1,3-thiazol-4-yl)ethanoic acid; Cyclopropanecarboxylic acid, 2-(4-carboxymethyl-2-thiazolyl)hydrazide (tautomer); 926246-95-9; 2-(2-Cyclopropanamidothiazol-4-yl)acetic acid
EINECS	Contact for details

Quality Control

Our 2-(2-Cyclopropaneamido-1,3-Thiazol-4-Yl)Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment and is available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after each use to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.